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Abstract
There is evidence for a disturbed perception and processing of emotional information in pathological anxiety. Using a rat
model of trait anxiety generated by selective breeding, we previously revealed differences in challenge-induced neuronal
activation in fear/anxiety-related brain areas between high (HAB) and low (LAB) anxiety rats. To confirm whether findings
generalize to other species, we used the corresponding HAB/LAB mouse model and investigated c-Fos responses to
elevated open arm exposure. Moreover, for the first time we included normal anxiety mice (NAB) for comparison. The results
confirm that HAB mice show hyperanxious behavior compared to their LAB counterparts, with NAB mice displaying an
intermediate anxiety phenotype. Open arm challenge revealed altered c-Fos response in prefrontal-cortical, limbic and
hypothalamic areas in HAB mice as compared to LAB mice, and this was similar to the differences observed previously in the
HAB/LAB rat lines. In mice, however, additional differential c-Fos response was observed in subregions of the amygdala,
hypothalamus, nucleus accumbens, midbrain and pons. Most of these differences were also seen between HAB and NAB
mice, indicating that it is predominately the HAB line showing altered neuronal processing. Hypothalamic hypoactivation
detected in LAB versus NAB mice may be associated with their low-anxiety/high-novelty-seeking phenotype. The detection
of similarly disturbed activation patterns in a key set of anxiety-related brain areas in two independent models reflecting
psychopathological states of trait anxiety confirms the notion that the altered brain activation in HAB animals is indeed
characteristic of enhanced (pathological) anxiety, providing information for potential targets of therapeutic intervention.
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Introduction
Pathological fear and anxiety and its physiological expression
can be conceptualized as representing a continuum, ranging from
persistent anxiety not attributable to specific factors to exaggerated
responses to a perceived threat or a bias towards interpreting
ambiguous situations as threatening [1]. Dysfunctional excitability
in neurons of the anxiety/fear circuitry is speculated to be a
common abnormality in anxiety disorders [1]. While it is well
established that certain brain areas are involved in the perception
and processing of acute fear (for review, see [2–4]), much less is
known about the regional nature of changes in proposed anxiety
circuitries (for review, see [5]) predisposing individuals to be
hyperanxious. One approach toward obtaining a better under-
standing of these mechanisms is to use psychogenetically selected
rodent lines, developed from a common foundation population
that exhibit consistent and robust differences in the selection
criterion. Using this strategy, various rat lines have been generated
that differ in certain aspects of emotionality including anxiety,
such as the Maudsley Reactive and Nonreactive strain, Roman
high and low avoidance rat lines, Tsukuba strains, and high/low
anxiety-related behavior (HAB/LAB) rat lines (for review, see [6–
9]). To our knowledge, corresponding mouse models selectively
bred for extremes in anxiety are not available, with one exception
(see below).
In HAB/LAB rats, systematic immediate early gene expression
studies succeeded in mapping differences in neuronal activity
patterns underlying behavioral responses to a variety of aversive
situations [10–14]. So far, no such information is available in mice.
Recently, HAB and LAB mouse lines have been established by
selective and bidirectional breeding for high (HAB) and low (LAB)
anxiety-related behavior measured on the elevated plus-maze
(EPM)[15,16]. Compared to LAB mice, HAB mice were more
anxious and showed increased risk assessment behavior in a
number of tests, including the EPM test, open-arm exposure test,
light/dark avoidance test and ultrasound vocalization test.
Moreover, unselected CD1 ‘‘normal’’ anxiety-related behavior
(NAB; for definition, see Material and Methods) mice, as well as
HAB/LAB F1 intercrosses, displayed intermediate behavioral
scores in most of the tasks performed [16].
In the present study, we aimed for the first time to investigate in
mice whether genetically determined differences in anxiety-related
behavior as well as risk assessment would be reflected by
differential stress-induced c-Fos expression as a reliable marker
of neuronal activation in key brain areas of anxiety circuitries
previously described in rats (for review, see [14]).
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of the EPM was chosen as a mild anxiety-based stressor. The
investigation of c-Fos in NAB mice provides an additional
advantage, as the intermediate phenotype of these animals may
act as a reference of changes in brain activity, suitable to
determine whether HAB or LAB mice reveal neuronal alterations.
By confirming similarly affected neuronal populations in an
additional model of a different species, the general significance of
the previous findings would be strengthened, suggesting the
difference in trait anxiety presumably being the cause. At the same
time, this cross-species replication would provide further informa-
tion as to possible effects of genetic drift, giving rise to genetic
differences that are unrelated to the selected phenotype.
Differences in c-Fos activation, in other words, could reflect both
the selection pressure and drift-related phenomena.
Materials and Methods
Animals
Ethics statement. The study described here was designed to
minimize animal suffering and number of animals used, and was
approved bythelocalEthicalCommitteesonAnimalCare and Use.
All animals tested were bred in the animal facilities of the Max
Plank Institute of Psychiatry in Munich (Germany) as described
previously [16]. Briefly, .250 animals from .25 litters of outbred
Swiss CD1 mice purchased from Charles River were used as a
starting point for selective and bidirectional breeding for anxiety-
related behavior on the EPM at the age of seven weeks, with at
least six families routinely maintained within each selected line.
Males and females that spent either the least or most time on the
open arms of the EPM were mated to establish the HAB and LAB
mouse lines. This intra-line approach was chosen to make sure
that the HAB/LAB lines show a maximum divergence in the
selected trait, while maintaining a high degree of similarity in non-
selected traits. All experiments in the present study were carried
out on inbred adult male HAB (n=14), LAB (n=13) and NAB
(n=13) mice (22–25g body weight; 13–14 weeks of age). The
animals were routinely tested at an age of 7 weeks in Munich with
HAB and LAB mice spending less than 10% and more than 50%
of their time, respectively, on the open arms of the EPM. This was
also the selection criterion. NAB mice are bred for ‘‘normal’’ (i.e.
intermediate) anxiety-related behavior. They were selected from a
group of CD1 mice maintained in the laboratory while HAB and
LAB lines were being selected. As .80% of CD1 mice spent
between 25% and 35% of their time on the open arms of the
EPM, this range was chosen for the selection of NAB mice without
any overlapping either with HAB or with LAB animals. While
CD1 mice in the parental generation were used as NAB controls
by Kro ¨mer et al. [16] and Kessler et al. [15], we then decided to
start inbreeding them in parallel with HAB and LAB mice to
further reduce variables that are unrelated to anxiety, such as
slight differences in body weight between outbred vs. inbred
animals. In the present study, HAB and LAB mice of generations
18–22 and NAB mice of generations 1–3 were used. Importantly,
in a wide variety of tests and parameters, the intermediate scores of
(bred) NAB, (purchased) CD1, and HAB/LAB F1 controls were
found to be similar if not identical ([16]; unpublished results). We
generated six independent families within the HAB, LAB and
NAB lines using a within-family selection design.
In Innsbruck, HAB, NAB and LAB animals were housed under
standard laboratory conditions (12:12 h light/dark cycle with
lights on at 7:00; 21uC; 50% humidity; pelleted food; and water ad
libitum) for 6 weeks in groups of 3–4 litter mates per cage. At least
24 h before the experiment, animals were taken in their home
cages to the experimental rooms for habituation. The behavioral
test was carried out during the light phase of the cycle (between
8:30 and 12:30 a.m.).
OA exposure
Mice (HAB: n=9, LAB: n=8, NAB: n=8) were placed in the
middle of the OA (5065 cm) of an EPM (facing the proximal
compartment). The maze was elevated 73 cm above the floor and
illuminated by a light intensity of 100 lux. Access to the neutralzone
andtheclosedarms of the maze wasprevented bya bar that made it
impossible for the mouse to leave the OA. The arm was thoroughly
cleaned with water before the introduction of each mouse and
divided into a distal, a middle and a proximal zone. The behavior of
the mice during the 5-min testing period was analyzed by an
automatic videotracking system (Videomot 2.0, TSE, Bad Hom-
burg, Germany). In addition, the test session was videotaped for
later analysis of the head-dip behavior by an experienced observer
using the Eventlog 1.0 (EMCO Software). The behavioral
parameters scored included the number of entries into the distal
zone of the OA, the time spent in the distal zone of the OA, total
distance traveled, number of head dips below the surface of the OA,
the time spent head dipping and the latency until the first head dip.
Immediately after behavioral testing, animals were returned to their
home cages. Animals assigned to the control (basal) group (n=5 for
all three lines) were not exposed to the OA and were taken directly
from their home cages for further analysis.
c-Fos immunohistochemistry
The maximum level of c-Fos protein can be detected between 1
and 3 h following an acute challenge, then it gradually disappears
from the cell nucleus [17–19]. Therefore, 2 h after the onset of the
OA exposure test, animals were deeply anesthetized with an
overdose of sodium pentobarbital (200 mg/kg) and transcardially
perfused with 100 ml of 0.9% saline followed by 100 mL of 4%
paraformaldehyde in 0.1 mol/L phosphate buffered solution (PBS,
pH 7.4). Mice not exposed to the test paradigm were treated
identically immediately after removal from their cages in the
experimental room. Brains were then removed and postfixed at
4uC overnight in 4% paraformaldehyde in PBS. Coronal sections
(100 mm) were cut with a Vibratome (Ted-Pella, Inc., Redding,
CA, USA) and collected in Immunobuffer. C-Fos immunoreac-
tivity was performed in three runs for i) the rostral (from Bregma
+1.94mm to +0.14mm), ii) the middle (from Bregma 20.82mm to
21.46mm) and iii) the caudal part (from Bregma 23.88mm to
25.40mm) of the mouse brain. Within a given run, sections of all
groups were processed simultaneously in order to avoid batch
effects. The sections were processed as described previously [20].
Briefly, sections were incubated for 72 h in a polyclonal rabbit
anti-c-Fos primary antibody (sc-52, Santa Cruz Biotechnology,
Santa Cruz, CA, USA) diluted (1:20000) in immunobuffer
(pH 7.4). The sections were then rinsed and placed in a
biotinylated goat anti-rabbit secondary antibody (1:200, Vector
Laboratories, Burlingame, CA, USA) for 24 h. An avidin-biotin-
horseradish peroxidase procedure (Vectastatin ABC Kit, Vector
laboratories, Burlingame, USA) with 3,39-diaminobenzidine
(DAB, Sigma, Germany) as chromogen was used to visualize c-
Fos positive cells. The incubation time with the DAB-solution was
10 min for all sections. The chromogen reaction was initiated by
the addition of the H2O2 solution (0.004%) and terminated after
7 min (colour change to brown) by adding Tris buffer (50mM).
The staining procedure generally yielded low background staining
and differential staining intensities of c-Fos positive cells. A cell was
considered as c-Fos-labeled (c-Fos positive), if the brown-black
DAB-stained nucleus was unambiguously darker than background
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staining. The lighting of the microscope was optimized for the best
visibility of c-Fos labeled cells and kept constant for all sections.
The c-Fos quantification was performed at different levels of the
brain in 59 different structures, which (amongst others) are known
to show stress-induced increase in c-Fos expression [13,21,22] .
Many of these regions have been implicated in the anxiety
circuitry (for review, see [5,23,24]). The anatomical localization of
c-Fos-positive cells was aided by use of adjacent Nissl stained
sections and the illustrations in a stereotaxic atlas [25]. The
anterior-posterior levels of sections included for detailed analysis
and associated structures are shown in Figure 1. The number of c-
Fos-positive cells was quantified bilaterally in a tissue area of
100 mm6100 mm. This was performed for the whole experiment
by one and the same well-experienced observer, who was blind to
the experimental groups. Generally, cell counting was performed
maximally for 3 h per day in the time period from 9 to 12 a.m.
Statistical Analysis
Statistical analysis using the Kolmogorov-Smirnov test and
Shapiro-Wilk test (Software: Statistica 7.1, Statsoft Inc.,USA)
revealed parametric (normal) distribution for the behavioral data
and the c-Fos data for most brain regions. Therefore, overall
statistical analysis of behavioral data was performed using the 1-
way ANOVA followed by Fischer LSD post hoc analysis. The
number of c-Fos positive cells was analysed by using the 2-way
ANOVA followed by (if there was a significant line x stress
interaction in ANOVA) Fischer LSD post hoc analysis to detect
statistically significant differences between the groups. Correlations
between the parameter distal arm entries and the number of c-Fos
cells were performed using the Spearman’s rank correlation
coefficient test. The level of significance was set at P,0.05. All
values were expressed as mean6SEM.
Results
OA behavior
ANOVA analysis revealed significant differences between the
three mouse lines for the parameters ‘‘distal time’’ (F(2,24)=5.759,
P=0.010), ‘‘distal entries’’ (F(2,24)=13.880, P,0.001), ‘‘distance
traveled’’ (F(2,24)=48.895, P,0.001), ‘‘time spent head dipping’’
(F(2,24)=14.810, P,0.001), ‘‘number of head dips’’
(F(2,24)=28.715, P,0.001) and ‘‘latency until first head dip’’
(F(2,24)=6.413, P=0.006). During OA exposure, the Fischer exact
revealed that the time spent in the distal zone and the number of
entries into the distal zone of the OA were significantly lower in
HAB than in LAB mice (see Figure 2). NAB animals displayed
intermediate anxiety-related behavior, although the difference for
the parameter ‘‘time spent head dipping’’ failed to reach statistical
significance from HAB and LAB lines (Figure 2a). Risk assessment
behavior as indicated by head dips below the surface of the OA [26]
was higher in LAB and NAB mice compared with their HAB
counterparts. In HAB animals the number of head dips and the
duration of head dipping were significantly lower, while the latency
until the first head dip was significantly higher as compared with
NAB and LAB mice. Head-dip behavior did not differ between
NAB and LAB mice (Figure 2b).
Line Differences in OA-induced c-Fos expression
An overview of the 59 brain areas in which c-Fos expression was
quantified is given in Figure 1. Mean numbers6SEM of cells
expressing c-Fos in these brain regions are shown in Table 1.
Basal c-Fos expression. In mice of the basal groups which
were not exposed to the OA, the number of cells expressing c-Fos
was low in most areas examined. Moderate numbers of c-Fos-
positive cells were, however, detected in some cortical, thalamic,
and hypothalamic areas. No differences in basal c-Fos expression
were observed among HAB, NAB and LAB mice (Table 1).
c-Fos expression after OA exposure. OA exposure induced
c-Fos expression in a variety of brain areas, with moderate to
pronounced increases in areas involved in stress responses (see
Table 1, 2-way ANOVA analysis for the factor stress), including
different cortical areas, limbic areas such as subregions of the
amygdala, the bed nucleus of the stria terminalis, areas of the
hippocampal formation, the lateral septum, the nucleus accumbens,
as well as the thalamic and hypothalamic nuclei, parts of the
periaqueductal gray (PAG) and diverse brainstem nuclei. Only in a
few areas did OA stress fail to induce a significant increase in c-Fos
expression, including in the medial orbital and granular insular
cortices, the medial and lateral globus pallidus, the caudate
putamen, the anterodorsal thalamic nucleus, the central nucleus
of the amygdala and the medial parabrachial nucleus.
2-way ANOVA analysis revealed a significant line x stress
interaction for the number of c-Fos positive cells in 18 out of 59
brain areas investigated, including the cingulate cortex, the
nucleus accumbens (core, shell), the lateral septum (ventral,
intermediate), the paraventricular hypothalamic nucleus (PVN),
the medial preoptic area, the lateral hypothalamic area, the
dorsomedial hypothalamic nucleus, the ventromedial hypotha-
lamic nucleus, the anterior hypothalamic nucleus, the medial
nucleus of the amygdala, the lateral nucleus of the amygdala, the
anterior cortical amygdala, the dentate gyrus, the caudal
periaqueductal gray (ventrolateral, dorsolateral) and the locus
coeruleus (LC). For details of statistics (F and P values) see Table 1.
In all 18 brain areas, post hoc analysis revealed a differential OA-
induced c-Fos response between HAB and LAB mice. The c-Fos
response to OA exposure was increased in HAB as compared with
LAB mice, in 16 areas, including the shell and the core region of the
nucleus accumbens, the ventral and intermediate part of the lateral
septum, the PVN, the lateral and anterior hypothalamic area, the
dorsomedial and ventromedial hypothalamic nucleus, the medial
preoptic area, the medial, lateral and anterior cortical amygdala, the
caudal PAG (ventrolateral, dorsolateral) and the LC (Figure 3,
Figure 4, Figure 5). Conversely, a lower number of c-Fos positive
cells inHAB thaninLAB animalswas found in2areas,thecingulate
cortexandthedentategyrusofthehippocampus(Figure4,Figure5).
In 15 of these 18 areas a similar difference in the neuronal
activation pattern was seen, when NAB were compared with HAB
mice. The exception was the PVN, the anterior hypothalamic area
and the caudal periaqueductal gray (ventrolateral), where the
statistically significant difference in the c-Fos response was lost
when HAB were compared with NAB animals. Thus, the neuronal
activation response of NAB and LAB mice was very similar in
most of these areas, but LAB mice displayed a lower c-Fos
response compared with NABs in the PVN, the anterior
hypothalamic area and the medial preoptic area (Figure 4). In
all other brain areas, OA-induced c-Fos expression in NAB mice
did not differ from HAB or LAB mice. Since we used a number of
comparisons (59 for each brain area), it should be noted that there
is the theoretical possibility of false positive results, although the
probability of this is very low.
Correlation analysis between distal arm entries and c-Fos
expression. Correlation analysis between OA distal arm entries
and c-Fos expression after OA exposure was performed for the 18
brain areas where HAB and LAB mice showed significant
differences in c-Fos response (see above). The Spearman test
revealed significant negative correlation for the PVN, the lateral
hypothalamic area, the dorsomedial hypothalamic nucleus, the
Brain Activation in Mice
PLoS ONE | www.plosone.org 3 April 2009 | Volume 4 | Issue 4 | e5346Figure 1. Schematic diagram showing the 59 areas in which c-Fos expression was quantified. Levels are based on the atlas of Franklin
and Paxinos (1997). Squares indicate the placement of grids for counting of c-Fos positive cells. Asterisks indicate the regions in which HAB mice
showed changes in OA-induced c-Fos expression as compared to LABs. AcB, nucleus (n.) accumbens; AcBc, n. accumbens core; AcBsh, n. accumbens
shell; ACo, anterior cortical n. of the amygdala; AD, anterodorsal thalamic n.; AH, anterior hypothalamic area; Arc, arcuate hypothalamic nucleus; BlA,
basolateral n. of the amygdala; BNST, bed n. of the stria terminalis; CA1, CA1 field of the hippocampus; CA3, CA3 field of the hippocampus; CeA,
central n. of the amygdala; Cg 1, cingulate ctx (area1); Cg 2, cingulate ctx (area2); Cl, Claustrum; CPu, caudate putamen; cPAGdl, caudal dorsolateral
periaqueductal gray; cPAGdm, caudal dorsomedial periaqueductal gray; cPAGl, caudal lateral periaqueductal gray; cPAGvl, caudal ventrolateral
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area, the medial preoptic area, the lateral septum (ventral), the
medial nucleus of the amygdala, the lateral nucleus of the amygdala
and the LC, indicating that higher anxiety behavior (fewer distal
entries) is correlated with enhanced c-Fos response in these areas.
Along these lines, a positive correlation was found for the dentate
gyrus. None of the other brain regions correlated significantly with
the distal arm entries during OA exposure. Details of the correlation
analysis (including R and P values) are given in Table 2.
Discussion
This study demonstrates that HAB mice display clear signs of a
hyperanxious phenotype in the OA exposure test as compared to
LAB mice, while NAB animals show intermediate anxiety-related
behavior. It furthermore confirms in large part the OA-induced
brain activity pattern previously found in the corresponding HAB/
LAB rat model (see [13]). The striking new finding of the present
HAB/LAB mouse study is that this mild anxiogenic stimulus
invoked differences in neuronal activation patterns in additional
brain areas, including subregions of the amygdala, the hypothal-
amus, the nucleus accumbens, the midbrain and the pons, and
that the OA-induced neuronal activation profile in NAB mice
resembled in large part that of LAB mice. Therefore it is suggested
that it is predominantly the HAB line that shows altered processing
of mild anxiety-provoking stimuli, thus substantiating the search
for correlates of anxiety-related phenomena particularly in this line
[7].
Line differences in OA behavior
The behavioral results of the present study confirm previous
observations demonstrating that HAB mice are more anxious [16]
Figure 2. Behavioral parameters of HAB, NAB and LAB mice measured in the 5-min exposure to the OA. (a) Time spent in distal zone,
entries into distal zone, total distance traveled. (b) Head-dip behavior. Values are expressed as mean6SEM. HAB: n=9, NAB: n=8, LAB: n=8; *
p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0005346.g002
periaqueductal gray; DEn, Endopiriform ctx, dorsal; DG, dentate gyrus; DMH, dorsomedial hypothalamic n.; DP, dorsal peduncular nucleus; DR, dorsal
raphe n.; GI, granular insular ctx; IL, infralimbic ctx; LA, lateral n. of the amygdala; LC, locus coeruleus; LGP, lateral globus pallidus; LH, lateral
hypothalamic area; LHb, lateral habenular n.; LPB, lateral parabrachial n.; LSD, lateral septal n. (dorsal); LSI, lateral septal n. (intermediate); LSV, lateral
septal n. (ventral); M1, primary motor ctx; M2, secondary motor ctx; MeA, medial amygdala; MGP, medial globus pallidus; MO, medial orbital cortex;
MPA, medial preoptic area; MPO, medial preoptic n.; MPB, medial parabrachial n.; PE, periventricular n; Pir, piriform ctx; PLCo, posterolateral cortical n.
of the amygdala; PrL, prelimbic ctx; PV, paraventricular thalamic n.; PVA, paraventricular thalamic n. (anterior); PVN, paraventricular hypothalamic n.;
rPAGdl, rostral dorsolateral periaqueductal gray; rPAGdm, rostral dorsomedial periaqueductal gray; rPAGl, rostral lateral periaqueductal gray; RSA,
retrosplenial agranular ctx; RSG, retrosplenial granular ctx; S1J, primary somatosensory cortex, jaw region; VMH, ventromedial hypothalamic n.
doi:10.1371/journal.pone.0005346.g001
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BASAL OPEN ARM 2-way ANOVA
HAB NAB LAB HAB NAB LAB (line x stress)
Brain regions (brain level)
Cortical areas
Prelimbic cortex ## 2.460.5 2.760.5 1.860.3 14.261.2 11.461.4 11.261.1 F(2,24)=1.300, P=0.297
Infralimbic cortex ## 1.560.7 1.260.1 1.060.4 10.261.0 9.361.6 7.761.1 F(2,24)=1.533, P=0.243
Cingulate cortex 1 (+1,94) ## 1.360.4 1.760.3 1.760.9 6.860.6 9.461.3 9.160.5 F(2,24)=5.958, P=0.010
Cingulate cortex 1 (+0,14) ## 1.560.4 2.060.8 2.060.8 17.961.6 16.662.5 19.762.1 F(2,24)=2.314, P=0.128
Cingulate cortex 2 ## 1.460.8 1.660.7 1.560.2 15.961.3 14.061.6 16.661.6 F(2,24)=0.480, P=0.626
Piriform cortex ## 3.860.8 5.860.7 5.161.5 18.261.8 14.862.8 15.861.3 F(2,24)=1.346, P=0.285
Primary motor cortex ## 1.760.6 2.560.7 2.860.8 6.060.8 5.861.4 7.161.0 F(2,24)=1.478, P=0.255
Secondary motor cortex ## 2.160.7 3.061.2 2.760.7 10:060.7 8.661.6 10.261.1 F(2,24)=11.278, P=0.281
Endopiriform cortex, dorsal ## 0.560.2 0.560.2 0.760.3 1.560.3 3.461.0 2.260.6 F(2,24)=2.219, P=0.138
Orbital cortex, medial 4.761.0 4.660.8 5.360.8 4.160.8 6.760.8 5.962.5 F(2,24)=0.115, P=0.892
Peduncular nucleus, dorsal ## 1.460.4 2.060.5 1.160.3 7.960.8 7.862.1 7.661.3 F(2,24)=3.276, P=0.061
Primary somatosensory ctx # 1.460.8 1.060.5 1.260.5 2.860.4 1.860.4 3.861.0 F(2,24)=0.899, P=0.424
Granular insular cortex 1.260.6 1.260.6 2.360.4 2.560.2 1.660.4 3.861.2 F(2,24)=0.523, P=0.602
Retrosplenial agranular cortex ## 3.660.9 4.561.6 6.162.7 27.964.8 22.462.8 22.962.5 F(2,24)=0.749, P=0.162
Retrosplenial granular cortex ## 1.560.7 2.260.5 1.660.5 16.962.1 15.662.6 20.261.8 F(2,24)=1.259, P=0.308
Basalganglia
Caudate putamen 0.260.1 0.360.1 0.260.1 0.160.1 0.460.2 0.260.1 F(2,24)=0.043, P=0.958
Lateral globus pallidus 0.260.1 0.260.2 0.360.1 0.660.2 0.860.3 0.860.1 F(2,24)=0.862, P=0.439
Medial globus pallidus 0.260.1 0.260.1 1.360.9 0.460.1 0.760.4 0.760.1 F(2,24)=0.321, P=0.729
Nucleus accumbens ## 0.860.3 0.760.4 0.660.3 7.760.7 6.861.4 6.160.5 F(2,24)=3.249, P=0.062
Nucleus accumbens, core ## 0.960.2 0.560.2 0.860.4 8.960.8 6.261.1 6.060.8 F(2,24)=9.120, P=0.002
Nucleus accumbens, shell ## 0.460.1 0.660.3 0.860.2 4.360.4 2.860.5 2.960.5 F(2,24)=7.004, P=0.006
Claustrum ## 2.060.5 2.460.5 2.560.4 11.560.8 10.162.2 9.360.7 F(2,24)=1.821, P=0.190
Striatal sections
Lateral septum, intermediate ## 0.860.3 0.860.2 1.461.7 12.861.3 9.162.1 9.661.2 F(2,24)=9.221, P=0.002
Lateral septum, ventral ## 6.560.6 7.960.4 6.361.7 17.860.7 10.061.5 10.360.9 F(2,24)=3.565, P=0.049
Lateral septum, dorsal # 0.560.2 1.560.5 0.460.2 3.460.6 2.660.9 4.660.7 F(2,24)=3.311, P=0.060
Bed n. of stria terminalis ## 1.360.4 2.060.3 2.561.0 8.161.3 6.461.4 8.161.1 F(2,24)=3.497, P=0.052
Thalamus
Paraventricular thalamic n. ## 9.360.9 10.260.6 8.061.5 42.663.7 35.062.8 33.862.6 F(2,24)=0.836, P=0.450
Lateral habenular nucleus ## 5.562.8 6.761.7 8.360.8 26.665.4 26.265.5 30.365.4 F(2,24)=0.183, P=0.834
Paraventricular n., anterior ## 4.560.7 5.360.6 5.360.6 11.761.3 13.361.8 10.361.2 F(2,24)=0.071, P=0.932
Anterodorsal thalamic nucleus 0.760.3 0.660.5 0.360.1 0.360.1 0.260.2 0.260.1 F(2,24)=0.390, P=0.683
Hypothalamus
Paraventricular hypothalamic n. ## 2.361.1 1.260.5 1.360.3 12.261.3 10.561.6 3.861.0 F(2,24)=12.115, P,0.001
Periventricular hypothalamic n. ## 2.460.2 2.460.7 3.761.2 7.660.7 6.661.9 7.660.8 F(2,24)=0.039, P=0.962
Medial preoptic nucleus ## 2.060.4 2.460.5 3.360.5 13.961.0 12.961.8 13.162.2 F(2,24)=1.048, P=0.371
Medial preoptic area ## 4.760.3 5.561.0 4.560.4 16.360.7 12.160.6 8.360.6 F(2,24)=27.728, P,0.001
Lateral hypothalamic area ## 2.060.3 2.760.3 3.660.7 11.460.8 4.960.2 4.660.5 F(2,24)=23.446, P,0.001
Dorsomedial hypothalamic n. ## 4.861.5 3.060.7 5.161.2 22.262.4 13.960.3 12.361.6 F(2,24)=10.068, P=0.001
Arcuate hypothalamic nucleus ## 2.660.5 2.460.6 1.760.3 8.661.4 7.362.0 9.761.7 F(2,24)=2.297, P=0.129
Ventromedial hypothalamic n. ## 1.360.3 1.960.1 2.960.8 15.561.4 5.660.6 7.361.4 F(2,24)=12.934, P,0.001
Anterior hypothalamic nucleus 6.861.0 9.762.1 6.060.6 13.260.6 10.660.5 6.860.5 F(2,24)=4.556, P=0.025
Amygdala
Central n. of the amygdala 2.260.3 1.560.7 2.460.8 3.460.5 2.960.6 3.560.9 F(2,24)=0.256, P=0.777
Medial n. of the amygdala ## 3.260.1 2.960.6 3.361.1 14.760.6 11.861.0 11.060.9 F(2,24)=4.284, P=0.048
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OA exposure test. This is consistent with the observations made in
HAB and LAB rats during OA exposure [13,27]. NAB mice
essentially displayed an intermediate anxiety-like phenotype
compared with the extreme lines, although their head dip
behavior was similar to that of the LAB line.
Interestingly, in the present study we noted reduced ‘‘total
distance traveled’’ of HAB animals compared with both LAB and
NAB mice. While the distance traveled, which is rather low due to
the small size of the OA, may be considered to reflect locomotor
activity, decreased activity is also considered to be a form of
anxiety in which a ‘‘behavioral inhibition system’’ is activated [3].
Therefore, immobility (behavioral inhibition) per se is proposed to
be an indirect sign of intense anxiety/fear states in rodents. This is
also reflected by the fact that HAB animals [16] and rodents in
general showing high levels of anxiety- and depression-like
behavior display reduced general locomotor activity [28–31] and
vice versa [32,33]. Moreover, while traveling similar distances,
NAB mice also clearly differed from LAB mice in anxiety-related
parameters, further supporting the critical role of anxiety (rather
than locomotor effects) in the behavioral divergence among HAB,
NAB and LAB animals as observed in the OA exposure test.
Differential c-Fos expression in response to OA exposure
in HAB and LAB mice
The development of anxiety-related symptoms is closely related
to stress coping [14,34–38]. Stress-induced neuronal activation is
thought to delineate neuronal stress circuitries in rats and mice
[22,39–43]. Exposure to the OA of an EPM is considered as a
mild stressor inducing higher fear/anxiety than exposure to the
closed arm [44–46]. Indeed, the present study revealed that mice
stressed by OA exposure, compared to non-stressed (basal) mice,
showed enhanced c-Fos expression in widespread brain regions
related to fear/anxiety.
While the OA-induced c-Fos response in HAB compared to
LAB rats was increased in 5 out of 8 differentially modulated brain
areas (the lateral septum [ventral part], the PVN [parvocellular
part], the medial preoptic area, the anterior hypothalamic area
and the lateral hypothalamic area), attenuated c-Fos response was
found in the cingulate cortex as well as in the dentate gyrus and
the CA3 region of the hippocampus [13]. Remarkably, in the
present study we were able to confirm these findings in the
corresponding mouse model. In all but one of these regions, HAB
and LAB mice displayed the same differences in neuronal
activation after exposure to the OA. Only in the CA3 region of
BASAL OPEN ARM 2-way ANOVA
HAB NAB LAB HAB NAB LAB (line x stress)
Brain regions (brain level)
Lateral n. of the amygdala ## 0.660.1 0.960.3 0.460.2 4.960.4 3.560.3 2.960.5 F(2,24)=5.901, P=0.011
Basolateral n. of the amygdala ## 1.360.7 1.560.4 1.860.4 7.060.9 6.560.9 6.960.6 F(2,24)=1.352, P=0.284
Posterolateral cortical amy. ## 1.460.2 1.960.7 1.260.5 8.261.3 10.060.7 7.362.3 F(2,24)=0.413, P=0.668
Anterior cortical amygdala ## 2.560.3 3.160.7 3.060.5 9.860.6 6.460.4 6.261.0 F(2,24)=5.800, P=0.011
BASAL OPEN ARM 2-way ANOVA
HAB NAB LAB HAB NAB LAB (line x stress)
Brain regions
Hippocampus
Dentate gyrus ## 33.064.5 32.464.5 35.463.9 64.566.5 110.1613.6 127.6610.8 F(2,24)=5.552, P=0.013
CA1 field ## 27.462.8 32.363.6 31.463.4 61.568.5 58.867.7 57.068.5 F(2,24)=0.412, P=0.668
CA3 field ## 18.861.9 17.462.7 23.963.6 59.766.9 63.964.2 58.264.6 F(2,24)=1.498, P=0.250
Midbrain/pons
PAG rostral, dorsomedial ## 7.661.8 6.260.6 5.960.5 16.761.6 12.362. 14.161.6 F(2,24)=2.048, P=0.158
PAG rostral, dorsolateral ## 4.060.8 3.960.2 3.060.2 12.760.5 9.360.6 8.460.6 F(2,24)=2.797, P=0.088
PAG rostral, lateral ## 5.060.5 5.360.8 5.361.2 24.961.4 20.262.6 24.461.3 F(2,24)=3.518, P=0.051
PAG caudal, dorsomedial ## 1.560.4 1.860.4 2.360.4 6.460.7 6.462.1 5.460.7
PAG caudal, ventrolateral ## 5.060.4 6.760.9 4.860.4 19.360.8 16.460.8 15.661.5 F(2,24)=3.587, P=0.049
PAG caudal, lateral ## 2.060.3 3.161.0 3.060.7 17.961.1 14.163.8 17.661.0 F(2,24)=2.721, P=0.093
PAG caudal, dorsolateral ## 2.560.7 3.760.7 2.760.7 13.261.3 6.761.5 6.961.5 F(2,24)=11.522, P=0.001
Dorsal raphe nucleus ## 1.060.2 1.860.3 1.560.3 7.861.4 6.361.1 6.862.2 F(2,24)=1.014, P=0.383
Lateral parabrachial nucleus ## 2.760.9 3.861.5 4.161.3 6.661.1 5.660.9 8.861.3 F(2,24)=1.474, P=0.255
Medial parabrachial nucleus 1.160.4 0.660.2 1.160.2 0.460.2 0.960.3 1.160.3 F(2,24)=0.966, P=0.399
Locus coeruleus ## 3.260.3 3.661.1 2.460.4 15.161.2 10.360.6 9.660.4 F(2,24)=11.983,P,0.001
Values are numbers of c-Fos positive cells/0.01 mm
2. (total number of c-Fos positive cells was quantified in the CA1 and CA3 region and the dentate gyrus of the
hippocampus). 2-way ANOVA analysis results for line x stress interaction are given in the right column (brain areas showing significant interaction are shown in bold). 2-
way ANOVA analysis results for the factor stress are indicated by # P,0.05, ## P,0.01 basal versus OA stress groups; basal groups: n=5, OA-groups: n=8–9;
doi:10.1371/journal.pone.0005346.t001
Table 1. cont.
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extensively discussed by Salome et al. [13], disturbances in these
brain areas and associated systems may contribute to behavioral
and neuroendocrine responses typical of high trait anxiety.
The present study in mice, however, identified a number of
additional brain areas showing increased c-Fos response in HAB
versus LAB mice not seen in the rat experiment. These included
various limbic areas (subregions of the amygdala, the dorsomedial
and ventromedial hypothalamic nucleus, the nucleus accumbens
[core and shell], the lateral septum) as well as PAG subregions and
the LC. Supporting the relationship between anxiety-like behavior
and c-Fos response in particular brain areas, we were able to
demonstrate a significant correlation between distal arm entries
and c-Fos response in specific amygdaloid and hypothalamic
regions, in the lateral septum ventral, in the LC, and in the dentate
gyrus. In the rat model, line differences in c-Fos response in these
more widespread regions were observed only when stronger
challenges were used, such as social defeat, airjet, FG-7142
injection or forced swimming (for review, see [14]). Hence, the
HAB/LAB mouse model may be particularly sensitive in reflecting
phenotype-specific neuronal activation. However, another expla-
nation could be that the additional differences not common to the
two species are not related to differences in trait anxiety. Future
studies using anxiolytic drugs and additional challenges not related
to the EPM may help to clarify this issue. While the HAB/NAB/
LAB lines are of the same CD1 background, we cannot completely
rule out the possibility of a different time course in c-Fos responses
between the lines. This may represent a potential limitation of the
present study. Nevertheless this seems unlikely given that all three
lines are of the same CD1 background.
A central finding of the present study is the evidence of a
hypersensitive amygdala and a hyposensitive prefrontal cortex
(cingulate cortex) in HAB mice. These areas are homologous with
important fear-/anxiety-related regions of the human brain [47–
49], thus resembling the situation in stressor-exposed post-
traumatic stress disorder patients with poor top-down control of
the amygdala by structures such as the medial prefrontal cortex
[50,51]. In the present study, OA exposure stress enhanced c-Fos
expression in the cingulate cortex in all three lines, but the
maximum level of activation was reduced in HAB mice compared
with LAB and NAB mice. This effect was not very pronounced.
However, since cingulate cortex hypoactivation was also found in
HAB rats after exposure to various stressors (for review, see [14]),
we believe that this response might be a general feature of HAB
rats and HAB mice mediating high anxiety levels during stress
exposure. Given that the amygdala is a central relay station
Figure 3. Representative microphotographs of c-Fos immunoreactivity in the amygdala. (a) Schematic diagram, based on the atlas of
Franklin and Paxinos (1997), showing the amygdala at the level of 21.46 (Bregma). The square indicates the placement of grids for counting of c-Fos-
positive cells in the medial nucleus of the amygdala (MeA). (b) Low magnification overview of the amygdala (21.46) of a HAB mouse under basal
conditions; Scale bar=500 mm; (c) High magnification, bright field photomicrographs of representative sections matched for comparable
rostrocaudal levels showing the distribution of c-Fos expression within the medial nucleus of the amygdala in HAB, NAB and LAB mice under basal
conditions and after OA exposure. Scale bar=100 mm;
doi:10.1371/journal.pone.0005346.g003
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(such as the PAG, the brain stem, and the hypothalamus) for the
processing, expression and integration of anxiety-related emotions
(e.g. [52–54]), it is likely that hyperactivation in the amygdala is
involved in the mediation of the increased anxiety-related
behavior of HAB mice. The association of fear- and anxiety-
related phenomena has recently been highlighted [55–58].
The PAG is well known to integrate limbic and emotional
inputs with a repertoire of behavioral and autonomic responses
[59–61], and the LC is also well established as being related to
anxiety disorders [34,62]; in addition, the HPA axis and
sympatoadrenal system [62–64] produce physiological and
behavioral responses to stressful stimuli (for review, see [65]).
Thus, hyperactivation of these areas as observed in HAB mice
may be a general feature of highly anxious rodents (see also [14]).
Activation patterns in NAB compared to HAB and LAB
mice
To resemble human studies, in which differences in neuronal
activity between anxiety patients and healthy subjects are assessed,
it is of relevance to include an additional group with ‘‘normal’’
anxiety in animal studies. Thus, for the first time, we here aimed
also to map immediate early gene expression in NAB mice and to
compare the c-Fos response with that in HAB and LAB mice. In
15 out of the identified 18 key brain areas showing differences in
the neuronal activation pattern between HAB and LAB animals,
Figure 4. Quantitative analysis of c-Fos immunoreactivity in HAB, NAB and LAB mice under basal conditions and after OA
exposure. Depicted are those areas (cortical, accumbal and hypothalamic areas), for which the Fischer LSD post hoc test revealed statistically
significant differences in OA-stress-induced c-Fos response in HAB, NAB and LAB mice. Each column indicates the mean6SEM number of c-Fos
positive cells in a tissue area of 0.01mm
2 (total c-Fos expression was quantified in the dentate gyrus). Basal groups: n=5, OA-exposure: HAB: n=9,
NAB: n=8, LAB: n=8; *p,0.05, **p,0.01 vs HAB OA-group; # p,0.05, ## p,0.01 vs corresponding basal group; + p,0.05, ++ p,0.01 vs LAB OA-
group;
doi:10.1371/journal.pone.0005346.g004
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Hence, with a few exceptions (see below), the neuronal activation
responses of NAB and LAB animals were largely similar,
indicating that in particular the increased anxiety-related pheno-
type of HAB mice may be associated with altered neuronal
processing within specific brain areas.
LAB compared to NAB mice showed differential OA-induced c-
Fos responses in some hypothalamic sites, namely the PVN, the
anterior hypothalamic area and the medial preoptic area. This
activationpatternmaybe associatedwiththe non-anxietyphenotype
ofLAB vsNAB mice,and/or with enhanced noveltyseeking ofthese
animals (see [66–69]). Since, however, not much information is
available concerning brain areas critically involved in extreme non-
anxiety, such a conclusion remains speculative at present.
In our intra-line approach, selection pressure was exerted on
anxiety-related behavior only, while a high degree of similarity was
maintained in non-selected traits. This, however, does not
necessarily mean that any difference detected between HAB and
LAB animals, including that in regional c-Fos expression, is
causally related to anxiety or anxiety-linked phenomena. Con-
founds include, for example, random genetic drift across time,
giving rise to genetic differences that are unrelated to the selected
phenotype. While drift-related risk cannot be entirely avoided, we
tried to reduce it by: (i) running independent families within HAB,
NAB and LAB lines [16]; (ii) replicating key findings of c-Fos
expression in both mice and rats, using similar inbreeding
protocols (this study and [13]); and (iii) showing that, in a
pharmacological validation approach, paroxetine treatment atten-
Figure 5. Quantitative analysis of c-Fos immunoreactivity in HAB, NAB and LAB mice under basal conditions and after OA
exposure. Depicted are those areas (septal, hippocampal, amygdalar and hind brain areas) for which the Fischer LSD post hoc test revealed
statistically significant differences in OA-stress-induced c-Fos response in HAB, NAB and LAB mice. Each column indicates the mean6SEM number of
c-Fos positive cells in a tissue area of 0.01mm
2 (total c-Fos expression was quantified in the dentate gyrus). Basal groups: n=5, OA-exposure: HAB:
n=9, NAB: n=8, LAB: n=8; *p,0.05, **p,0.01 vs HAB OA-group; # p,0.05, ## p,0.01 vs corresponding basal group; + p,0.05, ++ p,0.01 vs LAB
OA-group;
doi:10.1371/journal.pone.0005346.g005
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further confirming an association between neuronal excitability
and the behavioral phenotype beyond genetic drift. Future efforts
will focus on testing further how strongly c-Fos and anxiety-related
behavior are functionally related, including short-term selection
and F2 panel associations. Only convergent information from
multiple approaches will give rise to a more objective assessment of
drift-related compared to other risks.
In conclusion, the data presented here demonstrate that
differential c-Fos responses to an unpleasant emotional challenge
are found in specific limbic, cortical, hypothalamic and hindbrain
areas of HAB vs LAB mice. Remarkably, the key areas
differentially activated after OA exposure in the HAB vs. LAB
rat lines [13] could be confirmed in this corresponding mouse
model, supporting the notion that the altered brain activation
pattern in HAB animals may be a generalized feature, being
indeed characteristic of enhanced trait anxiety. Similar brain areas
were found to display altered activation processing also in anxiety
disorder patients (see references in [14]), underlining the
translational value of the present findings. The c-Fos response
pattern in NAB mice, which displayed intermediate behavioral
scores, was similar to that of LAB mice, both showing clear-cut
differences to that of HAB animals, suggesting that it is mainly the
HAB mouse line which may show altered neuronal activation at
least upon OA exposure. This activation pattern typical of the high
anxiety-related phenotype, however, may either indicate exagger-
ated activation of pathways mediating anxiety or represent
dysfunctional adaptive responses which normally serve to suppress
anxiety.
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